Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Ping An Good Doctor Files for Hong Kong IPO Expected to Raise $1 Billion

publication date: Jan 31, 2018

Ping An Healthcare and Technology, better known as Ping An Good Doctor, has successfully filed for a Hong Kong IPO. The much anticipated offering is expected to raise $1 billion, though the initial 520 page prospectus does not predict a value for the transaction. However, the IPO prospectus does reveal that Ping An Good Doctor booked $130 million in revenue during the first nine months of 2017, a 240% increase from a year earlier with a loss of nearly $80 million. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital